vs
Side-by-side financial comparison of Carlyle Group Inc. (CG) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
Carlyle Group Inc. is the larger business by last-quarter revenue ($1.9B vs $1.5B, roughly 1.3× BeOne Medicines Ltd.). Carlyle Group Inc. runs the higher net margin — 18.8% vs 4.4%, a 14.4% gap on every dollar of revenue. On growth, Carlyle Group Inc. posted the faster year-over-year revenue change (84.1% vs 32.8%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $-1.2B). Over the past eight quarters, Carlyle Group Inc.'s revenue compounded faster (66.2% CAGR vs 41.2%).
The Carlyle Group Inc. is an American multinational company with operations in private equity, alternative asset management and financial services. As of 2023, the company had $426 billion of assets under management.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
CG vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.9B | $1.5B |
| Net Profit | $358.1M | $66.5M |
| Gross Margin | — | 90.5% |
| Operating Margin | 24.3% | 12.4% |
| Net Margin | 18.8% | 4.4% |
| Revenue YoY | 84.1% | 32.8% |
| Net Profit YoY | 69.8% | 143.8% |
| EPS (diluted) | $0.96 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.9B | $1.5B | ||
| Q3 25 | $332.7M | $1.4B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $973.1M | $1.1B | ||
| Q4 24 | $1.0B | $1.1B | ||
| Q3 24 | $2.6B | $1.0B | ||
| Q2 24 | $1.1B | $929.2M | ||
| Q1 24 | $688.4M | $751.7M |
| Q4 25 | $358.1M | $66.5M | ||
| Q3 25 | $900.0K | $124.8M | ||
| Q2 25 | $319.7M | $94.3M | ||
| Q1 25 | $130.0M | $1.3M | ||
| Q4 24 | $210.9M | $-151.9M | ||
| Q3 24 | $595.7M | $-121.3M | ||
| Q2 24 | $148.2M | $-120.4M | ||
| Q1 24 | $65.6M | $-251.2M |
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% | ||
| Q1 24 | — | 83.4% |
| Q4 25 | 24.3% | 12.4% | ||
| Q3 25 | 25.8% | 11.5% | ||
| Q2 25 | 28.0% | 6.7% | ||
| Q1 25 | 17.6% | 1.0% | ||
| Q4 24 | 25.7% | -7.0% | ||
| Q3 24 | 29.9% | -12.0% | ||
| Q2 24 | 20.5% | -11.5% | ||
| Q1 24 | 17.5% | -34.8% |
| Q4 25 | 18.8% | 4.4% | ||
| Q3 25 | 0.3% | 8.8% | ||
| Q2 25 | 20.3% | 7.2% | ||
| Q1 25 | 13.4% | 0.1% | ||
| Q4 24 | 20.4% | -13.5% | ||
| Q3 24 | 22.6% | -12.1% | ||
| Q2 24 | 13.9% | -13.0% | ||
| Q1 24 | 9.5% | -33.4% |
| Q4 25 | $0.96 | $0.05 | ||
| Q3 25 | $0.00 | $0.08 | ||
| Q2 25 | $0.87 | $0.06 | ||
| Q1 25 | $0.35 | $0.00 | ||
| Q4 24 | $0.56 | $-0.10 | ||
| Q3 24 | $1.63 | $-0.09 | ||
| Q2 24 | $0.40 | $-0.09 | ||
| Q1 24 | $0.18 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.0B | $4.5B |
| Total DebtLower is stronger | — | $836.4M |
| Stockholders' EquityBook value | $7.1B | $4.4B |
| Total Assets | $29.1B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.0B | $4.5B | ||
| Q3 25 | $2.2B | $4.0B | ||
| Q2 25 | $1.3B | $2.8B | ||
| Q1 25 | $1.2B | $2.5B | ||
| Q4 24 | $1.3B | $2.6B | ||
| Q3 24 | $1.4B | $2.7B | ||
| Q2 24 | $914.8M | $2.6B | ||
| Q1 24 | $1.3B | $2.8B |
| Q4 25 | — | $836.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $7.1B | $4.4B | ||
| Q3 25 | $6.8B | $4.1B | ||
| Q2 25 | $6.7B | $3.8B | ||
| Q1 25 | $6.4B | $3.5B | ||
| Q4 24 | $6.3B | $3.3B | ||
| Q3 24 | $6.3B | $3.4B | ||
| Q2 24 | $5.7B | $3.4B | ||
| Q1 24 | $5.7B | $3.4B |
| Q4 25 | $29.1B | $8.2B | ||
| Q3 25 | $27.1B | $7.6B | ||
| Q2 25 | $25.1B | $6.3B | ||
| Q1 25 | $24.1B | $5.8B | ||
| Q4 24 | $23.1B | $5.9B | ||
| Q3 24 | $22.7B | $5.8B | ||
| Q2 24 | $22.3B | $5.7B | ||
| Q1 24 | $20.8B | $5.7B |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.2B | $417.3M |
| Free Cash FlowOCF − Capex | $-1.2B | $379.8M |
| FCF MarginFCF / Revenue | -65.1% | 25.4% |
| Capex IntensityCapex / Revenue | 2.2% | 2.5% |
| Cash ConversionOCF / Net Profit | -3.34× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $-3.4B | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.2B | $417.3M | ||
| Q3 25 | $-1.6B | $402.6M | ||
| Q2 25 | $-168.8M | $263.6M | ||
| Q1 25 | $-352.1M | $44.1M | ||
| Q4 24 | $-352.8M | $75.2M | ||
| Q3 24 | $791.9M | $188.4M | ||
| Q2 24 | $-1.3B | $-95.6M | ||
| Q1 24 | $71.1M | $-308.6M |
| Q4 25 | $-1.2B | $379.8M | ||
| Q3 25 | $-1.6B | $354.5M | ||
| Q2 25 | $-186.3M | $219.8M | ||
| Q1 25 | $-368.8M | $-12.3M | ||
| Q4 24 | $-379.5M | $-17.3M | ||
| Q3 24 | $772.8M | $54.7M | ||
| Q2 24 | $-1.3B | $-205.5M | ||
| Q1 24 | $56.9M | $-465.1M |
| Q4 25 | -65.1% | 25.4% | ||
| Q3 25 | -475.7% | 25.1% | ||
| Q2 25 | -11.8% | 16.7% | ||
| Q1 25 | -37.9% | -1.1% | ||
| Q4 24 | -36.8% | -1.5% | ||
| Q3 24 | 29.3% | 5.5% | ||
| Q2 24 | -120.4% | -22.1% | ||
| Q1 24 | 8.3% | -61.9% |
| Q4 25 | 2.2% | 2.5% | ||
| Q3 25 | 7.0% | 3.4% | ||
| Q2 25 | 1.1% | 3.3% | ||
| Q1 25 | 1.7% | 5.0% | ||
| Q4 24 | 2.6% | 8.2% | ||
| Q3 24 | 0.7% | 13.3% | ||
| Q2 24 | 1.7% | 11.8% | ||
| Q1 24 | 2.1% | 20.8% |
| Q4 25 | -3.34× | 6.28× | ||
| Q3 25 | -1732.78× | 3.22× | ||
| Q2 25 | -0.53× | 2.79× | ||
| Q1 25 | -2.71× | 34.71× | ||
| Q4 24 | -1.67× | — | ||
| Q3 24 | 1.33× | — | ||
| Q2 24 | -8.57× | — | ||
| Q1 24 | 1.08× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CG
| Fund Management Fee | $606.8M | 32% |
| Other | $528.7M | 28% |
| Global Private Equity Segment | $307.3M | 16% |
| Global Credit Segment | $238.0M | 13% |
| Carlyle Alp Invest Segment | $124.6M | 7% |
| Incentive Fee | $55.4M | 3% |
| Fee Related Performance Revenues | $29.2M | 2% |
| Investment Advice | $11.1M | 1% |
ONC
Segment breakdown not available.
